A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Brevinin-2-RA8 peptide precursor | Brevinin-2-RA8 peptide precursor was found in Odorrana andersonii (golden crossband frog). It has antimicrobial activity. Grade: >97% by HPLC. |  |
| Brevinin-2-RA9 peptide precursor | Brevinin-2-RA9 peptide precursor was found in Odorrana andersonii (golden crossband frog). It has antimicrobial activity. | |
| Brevinin-2Rb | Brevinin-2Rb was found in Rana ridibunda. It has antimicrobial activity. | |
| Brevinin-2Rc | Brevinin-2Rc has antimicrobial activity. The source of Brevinin-2Rc is Rana ridibunda. Grade: >97% by HPLC. | |
| Brevinin-2Rd | Brevinin-2Rd has antimicrobial activity. The source of Brevinin-2Rd is Rana ridibunda. | |
| Brevinin-2-related peptide | Brevinin-2-related peptide is first isolated from skin secretions of the mink frog Lithobates septentrionalis. Brevinin-2-related peptide shows broad-spectrum antimicrobial activity but its therapeutic potential is limited by moderate hemolytic activity. Synonyms: B2RP. | |
| Brevinin-2-RN1 | Brevinin-2-RN1 has antibacterial and antifungal activity. Brevinin-2-RN1 was found in Rana nigrovittata. Grade: >96% by HPLC. | |
| Brevinin-2-RN2 | Brevinin-2-RN2 has antibacterial and antifungal activity. Brevinin-2-RN2 was found in Rana nigrovittata. | |
| Brevinin-2RTa | Brevinin-2RTa is active against S. aureus ATCC2592, R. rhodochrous (Gram-poistive) and P. faecalis X29 (Gram-negative). Brevinin-2RTa was found in Amolops ricketti. Grade: >97% by HPLC. | |
| Brevinin-2RTb | Brevinin-2RTb was found in Amolops ricketti. It has antibacterial activity. | |
| Brevinin-2SHa antimicrobial peptide | Brevinin-2SHa antimicrobial peptide was found in Odorrana schmackeri. It has antimicrobial activity. | |
| Brevinin-2SKa | Brevinin-2SKa was found in Rana sakuraii. It has antimicrobial activity. | |
| Brevinin-2SKb | The source of Brevinin-2SKb is Rana sakuraii. It is active against E. coli (MIC=3 uM). Grade: >95% by HPLC. | |
| Brevinin-2SN1 | The source of Brevinin-2SN1 is Hylarana spinulosa. It is active against some Gram-negative and a variety of Gram-positive bacterial strains. Brevinin-2SN1 is also active against fungus C.glabrata 090902 but not against C.albicans. It shows hemolytic activity against human erythrocytes. | |
| Brevinin-2SN2 | The source of Brevinin-2SN2 is Hylarana spinulosa. It is active against some Gram-negative and a variety of Gram-positive bacterial strains. Brevinin-2SN2 is also active against fungus C.glabrata 090902 but not against C.albicans. It shows hemolytic activity against human erythrocytes. | |
| Brevinin-2SN2_2 antimicrobial peptide precursor | Brevinin-2SN2_2 antimicrobial peptide precursor is isolated from Hylarana spinulosa. It has antimicrobial activity. | |
| Brevinin-2SN3 | The source of Brevinin-2SN3 is Hylarana spinulosa. It is active against some Gram-negative and a variety of Gram-positive bacterial strains. Brevinin-2SN3 is also active against fungus C.glabrata 090902 but not against C.albicans. It shows hemolytic activity against human erythrocytes. Grade: >97% by HPLC. | |
| Brevinin-2SN4 | The source of Brevinin-2SN4 is Hylarana spinulosa. Brevinin-2SN4 is active against a variety of Gram-negative and Gram-positive bacterial strains. It is not active against fungi. Brevinin-2SN4 also shows very weak hemolytic activity against human erythrocytes. | |
| Brevinin-2SN4 antimicrobial peptide precursor | Brevinin-2SN4 antimicrobial peptide precursor is isolated from Hylarana spinulosa. It has antimicrobial activity. | |
| Brevinin 2Ta | Brevinin 2Ta is produced by Rana temporaria. B-2Ta exhibited remarkable antimicrobial and anticancer activities. | |
| Brevinin-2Tb | Brevinin-2Tb was found in Rana temporaria. It is an antimicrobial peptide. | |
| Brevinin-2Tc | Brevinin-2Tc was found in Rana temporaria. It contains one disulfide bond: 23, 29. Brevinin-2TC has antibacterial activity against representative Gram-negative and Gram-positive bacteria. Molecular formula: C150H242N40O36S2. Mole weight: 3245.89. | |
| Brevinin-2Td | Brevinin-2Td was found in Rana temporaria. It has antibacterial activity against representative Gram-negative and Gram-positive bacteria. | |
| Brevinin-2TP1_2 antimicrobial peptide precursor | Brevinin-2TP1_2 antimicrobial peptide precursor was originally isolated from Hylarana taipehensis. | |
| Brevinin-2TP1 antimicrobial peptide precursor | Brevinin-2TP1 antimicrobial peptide precursor was found in Hylarana taipehensis. | |
| Brevinin-2TR1_2 antimicrobial peptide precursor | Brevinin-2TR1_2 antimicrobial peptide precursor was originally isolated from Amolops torrentis. | |
| Brevinin-2TR2 antimicrobial peptide precursor | Brevinin-2TR2 antimicrobial peptide precursor was originally isolated from Amolops torrentis. | |
| Brevinin-2TSa | Brevinin-2TSa was found in Rana tsushimensis. Brevinin-2TSa has broad-spectrum growth inhibitory activity against a range of Gram-negative and Gram-positive bacteria (including methicillin-resistant S. aureus MRSA) (MIC< or=25 uM) and relatively low hemolytic activity against human erythrocytes (LD50=100 uM). Grade:>96% by HPLC. Molecular formula: C148H253N41O41S3. Mole weight: 3359.03. | |
| Brevioxime | Brevioxime is a heterocyclic antibiotic produced by Penicillum bervicompactum. Molecular formula: C15H22N2O3. Mole weight: 278.35. | |
| Breviscapine | Breviscapine is a crude flavonoid extract of Breviscapine, which is more than 85% of the active ingredient, Breviscapine. Breviscapine has a wide range of cardiovascular pharmacological activities, such as increasing blood flow, improving microcirculation, dilating blood vessels, reducing blood viscosity, promoting fibrinolysis, inhibiting platelet aggregation and thrombosis. Breviscapine has been used in the study of cerebral infarction and its sequelae, cerebral thrombosis, coronary heart disease and angina pectoris [1] [2]. Uses: Scientific research. Group: Natural products. Alternative Names: Breviscapinun. CAS No. 116122-36-2. Pack Sizes: 10 mM * 1 mL; 25 mg; 50 mg; 100 mg. Product ID: HY-107802. |  |
| Breviscapine Liposome | Breviscapine is a mixture of apigenin-7-O-β-D-glucuronide and scutellarin, which is widely used in cardiovascular and cerebrovascular diseases as it dilates cerebral blood vessels and resists platelet aggregation. This product is a PEGylated pre-formulated liposome with breviscapine. It is only for research purposes. Group: Drug-loaded liposome. Categories: liposomes, niosomes, ethosomes, and transfersomes. |  |
| Brexpiprazole | Brexpiprazole is a novel atypical antipsychotic drug. It is a D2 dopamine partial agonist called serotonin-dopamine activity modulator (SDAM). It is a drug candidate useful in treatment and prevention of mental disorders including CNS disorders. Uses: Brexpiprazole is approved for the treatment of schizophrenia, and as an adjunctive treatment for depression. it is a drug candidate useful in treatment and prevention of mental disorders including cns disorders. Synonyms: 7-[4-(4-(Benzo[b]thien-4-yl)-piperazin-1-yl)butoxy]-1H-quinolin-2-one; OPC 34712. Grade: > 95%. CAS No. 913611-97-9. Molecular formula: C25H27N3O2S. Mole weight: 433.58. | |
| Brexpiprazole | Brexpiprazole (OPC-34712), an atypical orally active antipsychotic agent, is a partial agonist of human 5-HT1A and dopamine D 2L receptor with K i s of 0.12 nM and 0.3 nM, respectively. Brexpiprazole is also a 5-HT2A receptor antagonist with a K i of 0.47 nM. Brexpiprazole also shows potent antagonist activity at human noradrenergic α 1B (K i =0.17 nM) and α 2C receptors (K i =0.59 nM) [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: OPC-34712. CAS No. 913611-97-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-15780. | |
| Brexpiprazole-d8-1 | Brexpiprazole-d 8 -1 (OPC-34712-d 8 -1) is the deuterium labeled Brexpiprazole (HY-15780) [1]. Brexpiprazole (OPC-34712), an atypical orally active antipsychotic agent, is a partial agonist of human 5-HT1A and dopamine D 2L receptor with K i s of 0.12 nM and 0.3 nM, respectively. Brexpiprazole is also a 5-HT2A receptor antagonist with a K i of 0.47 nM. Brexpiprazole also shows potent antagonist activity at human noradrenergic α1B ( K i =0.17 nM) and α2C receptors ( K i =0.59 nM) [2] [3]. Uses: Scientific research. Group: Isotope-labeled compounds. Alternative Names: OPC-34712-d8-1. CAS No. 1427049-19-1. Pack Sizes: 500 μg; 1 mg. Product ID: HY-15780S1. | |
| Brexpiprazole dihydrochloride | The hydrochloride salt form of Brexpiprazole, whihch is a D2 dopamine partial agonist called serotonin-dopamine activity modulator (SDAM). Brexpiprazole exhibits high affinity for h5-HT1A (partial agonist), h5-HT2A (antagonist), hD2L (partial agonist), hα1B (antagonist) and hα2C-adrenergic (antagonist) receptors (Ki values <1 nM). Synonyms: OPC 34712 dihydrochloride; 7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one dihydrochloride. Grade: 98%. CAS No. 2512192-75-3. Molecular formula: C25H27N3O2S.2HCl. Mole weight: 506.49. | |
| Brexpiprazole hydrochloride | The hydrochloride salt form of Brexpiprazole, whihch is a D2 dopamine partial agonist called serotonin-dopamine activity modulator (SDAM). Brexpiprazole exhibits high affinity for h5-HT1A (partial agonist), h5-HT2A (antagonist), hD2L (partial agonist), hα1B (antagonist) and hα2C-adrenergic (antagonist) receptors (Ki values <1 nM). Synonyms: 7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-2(1H)-Quinolinone hydrochloride; 7-[4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one hydrochloride. Grade: 98%. CAS No. 913612-38-1. Molecular formula: C25H27N3O2S.xHCl. Mole weight: 433.58 (free base). | |
| Brexpiprazole Impurity 10 | Brexpiprazole Impurity 10 is an impurity of Brexpiprazole, a drug used to counter psychiatric afflictions such as schizophrenia and major depressive disorder. Synonyms: m-Cinnamanisidide; N-(3-Methoxyphenyl)-3-phenylpropenamide. Grade: > 95%. CAS No. 15116-41-3. Molecular formula: C16H15NO2. Mole weight: 253.30. | |
| Brexpiprazole Impurity 10 | Brexpiprazole Impurity 10. Uses: For analytical and research use. Group: Impurity standards. CAS No. 15116-41-3. Molecular formula: C16H15NO2. Mole weight: 253.3. Catalog: APB15116413. |  |
| Brexpiprazole Impurity 20 | Brexpiprazole Impurity 20. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-(benzofuran-4-yl)piperazine. CAS No. 105685-34-5. Molecular formula: C12H14N2O. Mole weight: 202.25. Catalog: APB105685345. | |
| Brexpiprazole Impurity 38 | Brexpiprazole Impurity 38. Uses: For analytical and research use. Group: Impurity standards. CAS No. 102-92-1. Molecular formula: C9H7ClO. Mole weight: 166.6. Catalog: APB102921. | |
| Brexpiprazole Impurity 39 | Brexpiprazole Impurity 39. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-(benzo[b]thiophen-7-yl)piperazine. CAS No. 105685-06-1. Molecular formula: C12H14N2S. Mole weight: 218.32. Catalog: APB105685061. | |
| Brexpiprazole Impurity 40 | Brexpiprazole Impurity 40. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 4-(piperazin-1-yl)benzo[b]thiophene-2-carboxylic acid. CAS No. 1700655-67-9. Molecular formula: C13H14N2O2S. Mole weight: 262.33. Catalog: APB1700655679. | |
| Brexpiprazole Impurity 48 | Brexpiprazole Impurity 48. Uses: For analytical and research use. Group: Impurity standards. CAS No. 105684-85-3. Molecular formula: C12H15ClN2O. Mole weight: 238.72. Catalog: APB105684853. | |
| Brexpiprazole Impurity 75 | Brexpiprazole Impurity 75. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 4-(benzo[b]thiophen-4-yl)piperazine-1-carbaldehyde. CAS No. 1677681-04-7. Molecular formula: C13H14N2OS. Mole weight: 246.33. Catalog: APB1677681047. | |
| Brexpiprazole Impurity 76 | Brexpiprazole Impurity 76. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)ethanone. CAS No. 1700655-62-4. Molecular formula: C14H16N2OS. Mole weight: 260.35. Catalog: APB1700655624. | |
| Brexpiprazole Impurity 9 | Brexpiprazole Impurity 9 is an impurity of brexpiprazole and related pharmaceutical formulations. Brexpiprazole is a medication utilized to treat schizophrenia and major depressive disorder. Synonyms: 5-Hydroxyquinolin-2(1H)-one; 5-Hydroxy-2(1H)-quinolone; 5-Hydroxycarbostyril; NSC 134652. Grade: > 95%. CAS No. 31570-97-5. Molecular formula: C9H7NO2. Mole weight: 161.16. | |
| Brexpiprazole-[piperazin-d8] | Brexpiprazole-[piperazin-d8] is the labelled analogue of Brexpiprazole. Brexpiprazole is a partial agonist of dopamine D2 receptor used as an atypical antipsychotic. It was approved by FDA for the treatment of schizophrenia. Synonyms: Brexpiprazole-piperazin-D8; 7-[4-(4-(Benzo[b]thien-4-yl)-piperazin-1-yl)butoxy]-1H-quinolin-2-one-d8; Brexpiprazole-d8; 7-[4-[4-(1-Benzothiophen-4-yl)-2,2,3,3,5,5,6,6-d8-piperazin-1-yl]butoxy]-1H-quinolin-2-one. Grade: >95%. CAS No. 1427049-21-5. Molecular formula: C25H19D8N3O2S. Mole weight: 441.63. | |
| Brexpiprazole S-oxide | Brexpiprazole S-oxide is a main metabolite of Brexpiprazole and is metabolized by cytochrome P450 3A4 (CYP3A4). Brexpiprazole is an atypical antipsychotic agent and a partial agonist of human 5-HT1A and dopamine receptor. Synonyms: DM-3411; 7-[4-[4-(1-Oxidobenzo[b]thien-4-yl)-1-piperazinyl]butoxy]-2(1H)-quinolinone; 4-(4-{4-[(2-Oxo-1,2-dihydro-7-quinolinyl)oxy]butyl}-1-piperazinyl)-1-benzothiophenium-1-olate. Grade: ≥95%. CAS No. 1191900-51-2. Molecular formula: C25H27N3O3S. Mole weight: 449.57. | |
| BRF110 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| BRG1 (1480-1603) His tag human | recombinant, expressed in E. coli, ?90% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| BRG1-mt, K798R human | recombinant, expressed in insect cells, ?80% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| BRG1, wild type human | recombinant, expressed in insect cells, ?80% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| Briakinumab | Briakinumab is a human anti-IL-12 monoclonal antibody developed for the treatment of rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, and Crohn's Disease. Synonyms: ABT-874; ABT 874; ABT874. Grade: 95%. CAS No. 339308-60-0. Molecular formula: C6376H9874N1722O1992S44. Mole weight: 143.9 kDa. | |
| Briakinumab | Briakinumab (ABT-874) is a fully human anti- IL-12/23p40 monoclonal antibody. Briakinumab targets and neutralizes IL-12 and IL-23. Briakinumab can be used for the research of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: ABT-874. CAS No. 339308-60-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99486. | |
| Brialmontin 1 | Brialmontin 1 is a highly efficacious compound employed in the research of diverse cancer forms, encompassing breast, lung and colon malignancies manifesting remarkable anticancer potential through precise engagement with distinct molecular cascades, consequently studying malignant cell proliferation. Synonyms: NSC-646005. CAS No. 128585-08-0. Molecular formula: C22H28O5. Mole weight: 372.45. | |
| Brialmontin 2 | Brialmontin 2 is an avant-garde biomedical innovation, meticulously aims at studying and remedying intricate bacterial infections. CAS No. 128585-09-1. Molecular formula: C21H26O5. Mole weight: 358.43. | |
| Briciclib | Briciclib is a small molecule that suppresses cyclin D1 accumulation in cancer cells. It is a benzyl styryl sulfone analog, and a disodium phosphate ester prodrug of ON 013100, with potential antineoplastic activity. It may exhibit synergistic antitumor activity in combination with other chemotherapeutic agents. It inhibits the proliferation of MCL, gastric, breast and esophageal cancer cell lines at nanomolar concentrations (GI50 = 9.8 - 12.2 nM) in vitro. It binds to eIF4E, blocking cap-dependent translation of cyclin D1 and other cancer proteins and leads to tumor cell death in vitro. It is active in nonclinical tumor models when combined with several chemotherapeutics. Uses: Briciclib may exhibit synergistic antitumor activity in combination with other chemotherapeutic agents. it is active in nonclinical tumor models when combined with several chemotherapeutics. Synonyms: Phenol, 2-Methoxy-5-[[[(1E)-2-(2,4,6-triMethoxyphenyl)ethenyl]sulfonyl]Methyl]-, 1-(dihydrogen phosphate); ON-014185; (E)-5-[[(2,4,6-Trimethoxystyryl)sulfonyl]methyl]-2-methoxyphenyl dihydrogen phosphate; [2-methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]phenyl] dihydrogen phosphate. Grade: >98 %. CAS No. 865783-99-9. Molecular formula: C19H23O10PS. Mole weight: 474.42. | |
| Briciclib sodium | Briciclib, also known as ON 013105 or ON 014185, is a benzyl styryl sulfone analog, and a disodium phosphate ester prodrug of ON 013100, with potential antineoplastic activity. Upon hydrolysis, cyclin D modulator ON 013105 is converted to ON 013100, which blocks cyclin D mRNA translation and decreases protein expression of cyclin D. This may induce cell cycle arrest and apoptosis in cancer cells overexpressing cyclin D and eventually decrease tumor cell proliferation. This agent may exhibit synergistic antitumor activity in combination with other chemotherapeutic agents. Cyclin D, a member of the cyclin family of cell cycle regulators, plays a key role in cell cycle division and is often overexpressed in a variety of hematologic and solid tumors and is correlated with poor prognosis. Synonyms: ON-013105; ON013105; ON 013105; ON 014185; ON014185; ON-014185. Grade: >98%. CAS No. 865784-01-6. Molecular formula: C19H21Na2O10PS. Mole weight: 518.38. | |
| Brigatinib | Brigatinib, also known as AP-26113, is an orally active, potent and selective dual ALK/EGFR inhibitor. AP26113 is an orally bioavailable inhibitor of anaplastic lymphoma kinase (ALK; IC50 < 100 nM in Ba/F3 cells). AP26113 binds to and inhibits ALK kinase and ALK fusion proteins as well as EGFR and mutant forms. It blocks ALK activity and reduces growth in neuroblastoma cells, mouse xenograft, and Drosophila model systems harboring constitutively active ALK variants. Synonyms: AP26113. Grade: ≥98%. CAS No. 1197953-54-0. Molecular formula: C29H39ClN7O2P. Mole weight: 584.10. | |
| Brigatinib | Brigatinib (AP-26113) is a highly potent, selective and orally active ALK inhibitor, with an IC 50 of 0.6 nM. Brigatinib can be used for research of NSCLC [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: AP-26113. CAS No. 1197953-54-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-12857. | |
| Brigatinib C | Brigatinib C is a linker, as a part of PROTAC Linker to target HJM-561 (HY-156698). Uses: Scientific research. Group: Signaling pathways. CAS No. 1197958-75-0. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-150910. | |
| Bright electroless gold plating solution | Bright electroless gold plating solution. Group: Electronic materials. |  |
| Brigimadlin | Brigimadlin (BI 907828) is an orally active E3 ubiquitin-protein ligase MDM-2 inhibitor, preventing MDM-2 from negatively regulating the tumor suppressor p53. Brigimadlin can be used for antineoplastic research [1] [2] [3] [4]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BI 907828. CAS No. 2095116-40-6. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg. Product ID: HY-152859. | |
| Brij 35 | 100g Pack Size. Group: Detergents. Formula: C20H42O5. CAS No. 9002-92-0. Prepack ID 28156962-100g. Molecular Weight 362.54. See USA prepack pricing. |  |
| Brij 35 | 1kg Pack Size. Group: Detergents. Formula: C20H42O5. CAS No. 9002-92-0. Prepack ID 28156962-1kg. Molecular Weight 362.54. See USA prepack pricing. | |
| Brij 35 solution 20.0% w/v in water | 100ml Pack Size. Group: Analytical Reagents, Diagnostic Raw Materials. Formula: (C2H4O)nC12H26. CAS No. 9002-92-0. Prepack ID 90020920-100ml. See USA prepack pricing. | |
| Brij 35 solution 20.0% w/v in water | 500ml Pack Size. Group: Analytical Reagents, Diagnostic Raw Materials. Formula: (C2H4O)nC12H26. CAS No. 9002-92-0. Prepack ID 90020920-500ml. See USA prepack pricing. | |
| Brij 35 solution 20.4% w/v in water | 1lt Pack Size. Group: Biochemicals, Detergents, Diagnostic Raw Materials. Formula: (C2H4O)nC12H26. CAS No. 9002-92-0. Prepack ID 90021904-1lt. See USA prepack pricing. | |
| Brij 35 Solution 30% (w/v) | Brij 35 Solution 30% (w/v). Group: Biochemicals. Alternative Names: Polyoxyethylene (23) lauryl ether. Grades: Highly Purified. CAS No. 9002-92-0. Pack Sizes: 500g, 1kg, 2kg, 5kg, 10kg. Molecular Formula: C58H118O24, Molecular Weight: 1199.54. US Biological Life Sciences. |  Worldwide |
| Brij 35 Solution 30%(w/v) | Brij 35 Solution 30%(w/v). Group: Biochemicals. Grades: Reagent Grade. CAS No. 9002-92-0. Pack Sizes: 1Kg, 5Kg. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
